drugset / Trial / NCT01658995
Management of Etonogestrel Subdermal Implant-related Bleeding
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a double-blinded, randomized, prospective placebo-controlled clinical trial to be conducted within the Mayo Clinic and the Mayo Clinic Health System. The goal of the research study is to gather information to determine whether Doxycycline is effective for the treatment of unacceptable bleeding associated with the etonogestrel subdermal implant (ESI), as compared to placebo.
Timeline
- Start
- 2012-09-13
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxycycline | Small molecule | 100 mg | Oral |
Indications
No indication recorded.